Skip to product information
1 of 1

Cytokeratin 7 Recombinant Rabbit mAb (SDT-R028)

Cytokeratin 7 Recombinant Rabbit mAb (SDT-R028)

Catalog Number: S0B2065 Application: WB,IHC-P,ICC,FCM,IP Reactivity: Human Conjugation: Unconjugated Brand: Starter
Price:
Regular price $100 USD
Regular price Sale price $100 USD
Size:
For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Host Rabbit
Antigen Cytokeratin 7
Synonyms Cytokeratin-7 (CK-7); Keratin-7 (K7); Sarcolectin; Type-II keratin Kb7; KRT7
Location Cell membrane, Intracellular
Accession P08729
Clone Number SDT-R028
Antibody Type Recombinant mAb
Isotype IgG
Application WB, IHC-P, ICC, IP, ICFCM
Reactivity Hu
Purification Protein A
Concentration 0.25 mg/ml
Physical Appearance Liquid
Storage Buffer

PBS, 40% Glycerol, 0.05%BSA, 0.03% Proclin 300

Stability & Storage

12 months from date of receipt / reconstitution, -20 °C as supplied

Dilution


application dilution species
WB 1:500
IP 1:25
IHC 1:1000
ICC 1:50
ICFCM 1:500

Background

Cytokeratin 7 is the intermediate silk protein mainly expressed in epithelial cells. The heterodine of keratin consists of a polymerization filament by an acid -keratin (or type I keratin, keratin 9 to 23) and alkaline keratin (or type II keratin, keratin 1 to 8). Expression similar to but more limited than keratins 8 and 18 in simple, pseudostratified and ductal epithelium, mesothelium and urothelium. It's generally expressed (with some variation) in adenocarcinoma of lung, breast, thyroid, endometrium, cervix, ovary, salivary gland, upper GI tract, urothelial carcinoma, papillary renal cell carcinoma and Paget disease. It's generally negative (with some variation) in colorectal carcinoma, Merkel cell carcinoma, hepatocellular carcinoma, prostatic adenocarcinoma, adrenocortical tumors and squamous cell carcinoma.

Picture

Western Blot

WB result of Cytokeratin 7 Rabbit mAb

Primary antibody: Cytokeratin 7 Rabbit mAb at 1/500 dilution
Lane 1: MCF7 whole cell lysate 20 µg
Lane 2: T47D whole cell lysate 20 µg
Lane 3: Hela whole cell lysate 20 µg
Lane 4: SK-OV-3 whole cell lysate 20 µg
Negative control: MCF7 whole cell lysate

Secondary antibody: Goat Anti-Rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 52 kDa
Observed MW: 40~55 kDa

FC

Flow cytometric analysis of MCF7 (left) / HeLa (right) cells labelling Cytokeratin-7 antibody at 1/500 (0.1ug) dilution/ (red) compared with a Rabbit monoclonal IgG (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). Goat Anti-Rabbit IgG Alexa Fluor® 488 was used as the secondary antibody. Negative control: MCF7

IP

Cytokeratin 7 Rabbit mAb at 1/25 dilution (1µg) immunoprecipitating Cytokeratin 7 in 0.4mg T-47D whole cell lysate.
Western blot was performed on the immunoprecipitate using Cytokeratin 7 Rabbit mAb at 1/1000 dilution.
Secondary antibody (HRP) for IP was used at 1/400 dilution.
Lane 1: T-47D whole cell lysate 20µg(input)
Lane 2: Cytokeratin 7 Rabbit mAb IP in T-47D whole cell lysate
Lane 3: Rabbit monoclonal IgG IP in T-47D whole cell lysate
Predicted MW: 52 kDa
Observed MW: 40-55 kDa

Immunohistochemistry

IHC shows positive staining in paraffin-embedded human breast cancer.

Anti-Cytokeratin 7 antibody was used at 1/1000 dilution, followed by a Goat Anti-Rabbit IgG H&L (HRP) ready to use.

Counterstained with hematoxylin.

Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

IHC shows positive staining in paraffin-embedded human endometrial cancer.

Anti-Cytokeratin 7 antibody was used at 1/1000 dilution, followed by a Goat Anti-Rabbit IgG H&L (HRP) ready to use.

Counterstained with hematoxylin.

Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

IHC shows positive staining in paraffin-embeddedhuman pancreas cancer.

Anti-Cytokeratin 7 antibody was used at 1/1000 dilution, followed by a Goat Anti-Rabbit IgG H&L (HRP) ready to use.

Counterstained with hematoxylin.

Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

IHC shows positive staining in paraffin-embedded human placenta.

Anti-Cytokeratin 7 antibody was used at 1/1000 dilution, followed by a Goat Anti-Rabbit IgG H&L (HRP) ready to use.

Counterstained with hematoxylin.

Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

IHC shows positive staining in paraffin-embedded human kidney.

Anti-Cytokeratin 7 antibody was used at 1/1000 dilution, followed by a Goat Anti-Rabbit IgG H&L (HRP) ready to use. Counterstained with hematoxylin.

Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

IHC shows positive staining in paraffin-embedded human liver.

Anti-Cytokeratin 7 antibody was used at 1/1000 dilution, followed by a Goat Anti-Rabbit IgG H&L (HRP) ready to use. Counterstained with hematoxylin.

Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

Negative control.IHC shows negative staining in paraffin-embedded human colon.

Anti-Cytokeratin 7 antibody was used at 1/500 dilution, followed by a Goat Anti-Rabbit IgG H&L (HRP) ready to use. Counterstained with hematoxylin.

Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)